Industry Research Reports
Home > Reports > Medical Care > Competent Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Competent Cells- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Care
Published Date: 2025-01-16
Pages: 155 Pages
Report ld: 3479888
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Competent Cells Market Size(US$)
CAGR 2025-2031
9.5%
Market Size,2031
USD 4,456
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 2,585 million
Market Forecast in 2031(Value)
US$ 4,456 million
CAGR
9.5%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Competent Cells was estimated to be worth US$ 2382 million in 2024 and is forecast to a readjusted size of US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.
North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.
In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.
This report aims to provide a comprehensive presentation of the global market for Competent Cells, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Competent Cells by region & country, by Type, and by Application.
The Competent Cells market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Competent Cells.
MARKET SEGMENTATION
By Company
- Merck KGaA
- Thermo Fisher Scientific
- Agilent Technologies
- Takara Bio
- Promega Corporation
- Beijing TransGen Biotech
- GeneScript Corporation
- Yeastern Biotech
- New England Biolabs
- QIAGEN N.V.
- OriGene Technologies
- Lucigen
- Zymo Research
- Bio-Rad Laboratories
- Bioline
- Delphi Genetics
- IBA GmBH
- Cell Applications
- BioDynamics Laboratory
- Scarab Genomics
- GCC Biotech
- SMOBIO Technology
- Edge BioSystems
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Chemically Competent Cells
- Electrocompetent Cells
Segment by Application
- Subcloning & Routine Cloning
- Phage Display Library Construction
- Toxic/Unstable DNA Cloning
- High-Throughput Cloning
- Protein Expression
- Mutagenesis
- Single-Stranded DNA Production
- Bacmid Creation
- Cre-Lox Recombination (PIR1/PIR2)
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Competent Cells company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Competent Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Competent Cells in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Competent Cells Product Introduction
1.2 Global Competent Cells Market Size Forecast (2020-2031)
1.3 Competent Cells Market Trends & Drivers
1.3.1 Competent Cells Industry Trends
1.3.2 Competent Cells Market Drivers & Opportunity
1.3.3 Competent Cells Market Challenges
1.3.4 Competent Cells Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Competent Cells Players Revenue Ranking (2024)
2.2 Global Competent Cells Revenue by Company (2020-2025)
2.3 Key Companies Competent Cells Manufacturing Base Distribution and Headquarters
2.4 Key Companies Competent Cells Product Offered
2.5 Key Companies Time to Begin Mass Production of Competent Cells
2.6 Competent Cells Market Competitive Analysis
2.6.1 Competent Cells Market Concentration Rate (2020-2025)
2.6.2 Global 5 and 10 Largest Companies by Competent Cells Revenue in 2024
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Competent Cells as of 2024)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chemically Competent Cells
3.1.2 Electrocompetent Cells
3.2 Global Competent Cells Sales Value by Type
3.2.1 Global Competent Cells Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Competent Cells Sales Value, by Type (2020-2031)
3.2.3 Global Competent Cells Sales Value, by Type (%) (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Subcloning & Routine Cloning
4.1.2 Phage Display Library Construction
4.1.3 Toxic/Unstable DNA Cloning
4.1.4 High-Throughput Cloning
4.1.5 Protein Expression
4.1.6 Mutagenesis
4.1.7 Single-Stranded DNA Production
4.1.8 Bacmid Creation
4.1.9 Cre-Lox Recombination (PIR1/PIR2)
4.2 Global Competent Cells Sales Value by Application
4.2.1 Global Competent Cells Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Competent Cells Sales Value, by Application (2020-2031)
4.2.3 Global Competent Cells Sales Value, by Application (%) (2020-2031)
5 Segmentation by Region
5.1 Global Competent Cells Sales Value by Region
5.1.1 Global Competent Cells Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Competent Cells Sales Value by Region (2020-2025)
5.1.3 Global Competent Cells Sales Value by Region (2026-2031)
5.1.4 Global Competent Cells Sales Value by Region (%), (2020-2031)
5.2 North America
5.2.1 North America Competent Cells Sales Value, 2020-2031
5.2.2 North America Competent Cells Sales Value by Country (%), 2024 VS 2031
5.3 Europe
5.3.1 Europe Competent Cells Sales Value, 2020-2031
5.3.2 Europe Competent Cells Sales Value by Country (%), 2024 VS 2031
5.4 Asia Pacific
5.4.1 Asia Pacific Competent Cells Sales Value, 2020-2031
5.4.2 Asia Pacific Competent Cells Sales Value by Region (%), 2024 VS 2031
5.5 South America
5.5.1 South America Competent Cells Sales Value, 2020-2031
5.5.2 South America Competent Cells Sales Value by Country (%), 2024 VS 2031
5.6 Middle East & Africa
5.6.1 Middle East & Africa Competent Cells Sales Value, 2020-2031
5.6.2 Middle East & Africa Competent Cells Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Competent Cells Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Competent Cells Sales Value, 2020-2031
6.3 United States
6.3.1 United States Competent Cells Sales Value, 2020-2031
6.3.2 United States Competent Cells Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Competent Cells Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Competent Cells Sales Value, 2020-2031
6.4.2 Europe Competent Cells Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Competent Cells Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Competent Cells Sales Value, 2020-2031
6.5.2 China Competent Cells Sales Value by Type (%), 2024 VS 2031
6.5.3 China Competent Cells Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Competent Cells Sales Value, 2020-2031
6.6.2 Japan Competent Cells Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Competent Cells Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Competent Cells Sales Value, 2020-2031
6.7.2 South Korea Competent Cells Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Competent Cells Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Competent Cells Sales Value, 2020-2031
6.8.2 Southeast Asia Competent Cells Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Competent Cells Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Competent Cells Sales Value, 2020-2031
6.9.2 India Competent Cells Sales Value by Type (%), 2024 VS 2031
6.9.3 India Competent Cells Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Merck KGaA
7.1.1 Merck KGaA Profile
7.1.2 Merck KGaA Main Business
7.1.3 Merck KGaA Competent Cells Products, Services and Solutions
7.1.4 Merck KGaA Competent Cells Revenue (US$ Million) & (2020-2025)
7.1.5 Merck KGaA Recent Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Profile
7.2.2 Thermo Fisher Scientific Main Business
7.2.3 Thermo Fisher Scientific Competent Cells Products, Services and Solutions
7.2.4 Thermo Fisher Scientific Competent Cells Revenue (US$ Million) & (2020-2025)
7.2.5 Thermo Fisher Scientific Recent Developments
7.3 Agilent Technologies
7.3.1 Agilent Technologies Profile
7.3.2 Agilent Technologies Main Business
7.3.3 Agilent Technologies Competent Cells Products, Services and Solutions
7.3.4 Agilent Technologies Competent Cells Revenue (US$ Million) & (2020-2025)
7.3.5 Agilent Technologies Recent Developments
7.4 Takara Bio
7.4.1 Takara Bio Profile
7.4.2 Takara Bio Main Business
7.4.3 Takara Bio Competent Cells Products, Services and Solutions
7.4.4 Takara Bio Competent Cells Revenue (US$ Million) & (2020-2025)
7.4.5 Takara Bio Recent Developments
7.5 Promega Corporation
7.5.1 Promega Corporation Profile
7.5.2 Promega Corporation Main Business
7.5.3 Promega Corporation Competent Cells Products, Services and Solutions
7.5.4 Promega Corporation Competent Cells Revenue (US$ Million) & (2020-2025)
7.5.5 Promega Corporation Recent Developments
7.6 Beijing TransGen Biotech
7.6.1 Beijing TransGen Biotech Profile
7.6.2 Beijing TransGen Biotech Main Business
7.6.3 Beijing TransGen Biotech Competent Cells Products, Services and Solutions
7.6.4 Beijing TransGen Biotech Competent Cells Revenue (US$ Million) & (2020-2025)
7.6.5 Beijing TransGen Biotech Recent Developments
7.7 GeneScript Corporation
7.7.1 GeneScript Corporation Profile
7.7.2 GeneScript Corporation Main Business
7.7.3 GeneScript Corporation Competent Cells Products, Services and Solutions
7.7.4 GeneScript Corporation Competent Cells Revenue (US$ Million) & (2020-2025)
7.7.5 GeneScript Corporation Recent Developments
7.8 Yeastern Biotech
7.8.1 Yeastern Biotech Profile
7.8.2 Yeastern Biotech Main Business
7.8.3 Yeastern Biotech Competent Cells Products, Services and Solutions
7.8.4 Yeastern Biotech Competent Cells Revenue (US$ Million) & (2020-2025)
7.8.5 Yeastern Biotech Recent Developments
7.9 New England Biolabs
7.9.1 New England Biolabs Profile
7.9.2 New England Biolabs Main Business
7.9.3 New England Biolabs Competent Cells Products, Services and Solutions
7.9.4 New England Biolabs Competent Cells Revenue (US$ Million) & (2020-2025)
7.9.5 New England Biolabs Recent Developments
7.10 QIAGEN N.V.
7.10.1 QIAGEN N.V. Profile
7.10.2 QIAGEN N.V. Main Business
7.10.3 QIAGEN N.V. Competent Cells Products, Services and Solutions
7.10.4 QIAGEN N.V. Competent Cells Revenue (US$ Million) & (2020-2025)
7.10.5 QIAGEN N.V. Recent Developments
7.11 OriGene Technologies
7.11.1 OriGene Technologies Profile
7.11.2 OriGene Technologies Main Business
7.11.3 OriGene Technologies Competent Cells Products, Services and Solutions
7.11.4 OriGene Technologies Competent Cells Revenue (US$ Million) & (2020-2025)
7.11.5 OriGene Technologies Recent Developments
7.12 Lucigen
7.12.1 Lucigen Profile
7.12.2 Lucigen Main Business
7.12.3 Lucigen Competent Cells Products, Services and Solutions
7.12.4 Lucigen Competent Cells Revenue (US$ Million) & (2020-2025)
7.12.5 Lucigen Recent Developments
7.13 Zymo Research
7.13.1 Zymo Research Profile
7.13.2 Zymo Research Main Business
7.13.3 Zymo Research Competent Cells Products, Services and Solutions
7.13.4 Zymo Research Competent Cells Revenue (US$ Million) & (2020-2025)
7.13.5 Zymo Research Recent Developments
7.14 Bio-Rad Laboratories
7.14.1 Bio-Rad Laboratories Profile
7.14.2 Bio-Rad Laboratories Main Business
7.14.3 Bio-Rad Laboratories Competent Cells Products, Services and Solutions
7.14.4 Bio-Rad Laboratories Competent Cells Revenue (US$ Million) & (2020-2025)
7.14.5 Bio-Rad Laboratories Recent Developments
7.15 Bioline
7.15.1 Bioline Profile
7.15.2 Bioline Main Business
7.15.3 Bioline Competent Cells Products, Services and Solutions
7.15.4 Bioline Competent Cells Revenue (US$ Million) & (2020-2025)
7.15.5 Bioline Recent Developments
7.16 Delphi Genetics
7.16.1 Delphi Genetics Profile
7.16.2 Delphi Genetics Main Business
7.16.3 Delphi Genetics Competent Cells Products, Services and Solutions
7.16.4 Delphi Genetics Competent Cells Revenue (US$ Million) & (2020-2025)
7.16.5 Delphi Genetics Recent Developments
7.17 IBA GmBH
7.17.1 IBA GmBH Profile
7.17.2 IBA GmBH Main Business
7.17.3 IBA GmBH Competent Cells Products, Services and Solutions
7.17.4 IBA GmBH Competent Cells Revenue (US$ Million) & (2020-2025)
7.17.5 IBA GmBH Recent Developments
7.18 Cell Applications
7.18.1 Cell Applications Profile
7.18.2 Cell Applications Main Business
7.18.3 Cell Applications Competent Cells Products, Services and Solutions
7.18.4 Cell Applications Competent Cells Revenue (US$ Million) & (2020-2025)
7.18.5 Cell Applications Recent Developments
7.19 BioDynamics Laboratory
7.19.1 BioDynamics Laboratory Profile
7.19.2 BioDynamics Laboratory Main Business
7.19.3 BioDynamics Laboratory Competent Cells Products, Services and Solutions
7.19.4 BioDynamics Laboratory Competent Cells Revenue (US$ Million) & (2020-2025)
7.19.5 BioDynamics Laboratory Recent Developments
7.20 Scarab Genomics
7.20.1 Scarab Genomics Profile
7.20.2 Scarab Genomics Main Business
7.20.3 Scarab Genomics Competent Cells Products, Services and Solutions
7.20.4 Scarab Genomics Competent Cells Revenue (US$ Million) & (2020-2025)
7.20.5 Scarab Genomics Recent Developments
7.21 GCC Biotech
7.21.1 GCC Biotech Profile
7.21.2 GCC Biotech Main Business
7.21.3 GCC Biotech Competent Cells Products, Services and Solutions
7.21.4 GCC Biotech Competent Cells Revenue (US$ Million) & (2020-2025)
7.21.5 GCC Biotech Recent Developments
7.22 SMOBIO Technology
7.22.1 SMOBIO Technology Profile
7.22.2 SMOBIO Technology Main Business
7.22.3 SMOBIO Technology Competent Cells Products, Services and Solutions
7.22.4 SMOBIO Technology Competent Cells Revenue (US$ Million) & (2020-2025)
7.22.5 SMOBIO Technology Recent Developments
7.23 Edge BioSystems
7.23.1 Edge BioSystems Profile
7.23.2 Edge BioSystems Main Business
7.23.3 Edge BioSystems Competent Cells Products, Services and Solutions
7.23.4 Edge BioSystems Competent Cells Revenue (US$ Million) & (2020-2025)
7.23.5 Edge BioSystems Recent Developments
8 Industry Chain Analysis
8.1 Competent Cells Industrial Chain
8.2 Competent Cells Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Competent Cells Sales Model
8.5.2 Sales Channel
8.5.3 Competent Cells Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Competent Cells Market Trends
Table 2. Competent Cells Market Drivers & Opportunity
Table 3. Competent Cells Market Challenges
Table 4. Competent Cells Market Restraints
Table 5. Global Competent Cells Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Competent Cells Revenue Market Share by Company (2020-2025)
Table 7. Key Companies Competent Cells Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Competent Cells Product Type
Table 9. Key Companies Time to Begin Mass Production of Competent Cells
Table 10. Global Competent Cells Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Competent Cells as of 2024)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Competent Cells Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 14. Global Competent Cells Sales Value by Type (2020-2025) & (US$ Million)
Table 15. Global Competent Cells Sales Value by Type (2026-2031) & (US$ Million)
Table 16. Global Competent Cells Sales Market Share in Value by Type (2020-2025)
Table 17. Global Competent Cells Sales Market Share in Value by Type (2026-2031)
Table 18. Global Competent Cells Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 19. Global Competent Cells Sales Value by Application (2020-2025) & (US$ Million)
Table 20. Global Competent Cells Sales Value by Application (2026-2031) & (US$ Million)
Table 21. Global Competent Cells Sales Market Share in Value by Application (2020-2025)
Table 22. Global Competent Cells Sales Market Share in Value by Application (2026-2031)
Table 23. Global Competent Cells Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 24. Global Competent Cells Sales Value by Region (2020-2025) & (US$ Million)
Table 25. Global Competent Cells Sales Value by Region (2026-2031) & (US$ Million)
Table 26. Global Competent Cells Sales Value by Region (2020-2025) & (%)
Table 27. Global Competent Cells Sales Value by Region (2026-2031) & (%)
Table 28. Key Countries/Regions Competent Cells Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 29. Key Countries/Regions Competent Cells Sales Value, (2020-2025) & (US$ Million)
Table 30. Key Countries/Regions Competent Cells Sales Value, (2026-2031) & (US$ Million)
Table 31. Merck KGaA Basic Information List
Table 32. Merck KGaA Description and Business Overview
Table 33. Merck KGaA Competent Cells Products, Services and Solutions
Table 34. Revenue (US$ Million) in Competent Cells Business of Merck KGaA (2020-2025)
Table 35. Merck KGaA Recent Developments
Table 36. Thermo Fisher Scientific Basic Information List
Table 37. Thermo Fisher Scientific Description and Business Overview
Table 38. Thermo Fisher Scientific Competent Cells Products, Services and Solutions
Table 39. Revenue (US$ Million) in Competent Cells Business of Thermo Fisher Scientific (2020-2025)
Table 40. Thermo Fisher Scientific Recent Developments
Table 41. Agilent Technologies Basic Information List
Table 42. Agilent Technologies Description and Business Overview
Table 43. Agilent Technologies Competent Cells Products, Services and Solutions
Table 44. Revenue (US$ Million) in Competent Cells Business of Agilent Technologies (2020-2025)
Table 45. Agilent Technologies Recent Developments
Table 46. Takara Bio Basic Information List
Table 47. Takara Bio Description and Business Overview
Table 48. Takara Bio Competent Cells Products, Services and Solutions
Table 49. Revenue (US$ Million) in Competent Cells Business of Takara Bio (2020-2025)
Table 50. Takara Bio Recent Developments
Table 51. Promega Corporation Basic Information List
Table 52. Promega Corporation Description and Business Overview
Table 53. Promega Corporation Competent Cells Products, Services and Solutions
Table 54. Revenue (US$ Million) in Competent Cells Business of Promega Corporation (2020-2025)
Table 55. Promega Corporation Recent Developments
Table 56. Beijing TransGen Biotech Basic Information List
Table 57. Beijing TransGen Biotech Description and Business Overview
Table 58. Beijing TransGen Biotech Competent Cells Products, Services and Solutions
Table 59. Revenue (US$ Million) in Competent Cells Business of Beijing TransGen Biotech (2020-2025)
Table 60. Beijing TransGen Biotech Recent Developments
Table 61. GeneScript Corporation Basic Information List
Table 62. GeneScript Corporation Description and Business Overview
Table 63. GeneScript Corporation Competent Cells Products, Services and Solutions
Table 64. Revenue (US$ Million) in Competent Cells Business of GeneScript Corporation (2020-2025)
Table 65. GeneScript Corporation Recent Developments
Table 66. Yeastern Biotech Basic Information List
Table 67. Yeastern Biotech Description and Business Overview
Table 68. Yeastern Biotech Competent Cells Products, Services and Solutions
Table 69. Revenue (US$ Million) in Competent Cells Business of Yeastern Biotech (2020-2025)
Table 70. Yeastern Biotech Recent Developments
Table 71. New England Biolabs Basic Information List
Table 72. New England Biolabs Description and Business Overview
Table 73. New England Biolabs Competent Cells Products, Services and Solutions
Table 74. Revenue (US$ Million) in Competent Cells Business of New England Biolabs (2020-2025)
Table 75. New England Biolabs Recent Developments
Table 76. QIAGEN N.V. Basic Information List
Table 77. QIAGEN N.V. Description and Business Overview
Table 78. QIAGEN N.V. Competent Cells Products, Services and Solutions
Table 79. Revenue (US$ Million) in Competent Cells Business of QIAGEN N.V. (2020-2025)
Table 80. QIAGEN N.V. Recent Developments
Table 81. OriGene Technologies Basic Information List
Table 82. OriGene Technologies Description and Business Overview
Table 83. OriGene Technologies Competent Cells Products, Services and Solutions
Table 84. Revenue (US$ Million) in Competent Cells Business of OriGene Technologies (2020-2025)
Table 85. OriGene Technologies Recent Developments
Table 86. Lucigen Basic Information List
Table 87. Lucigen Description and Business Overview
Table 88. Lucigen Competent Cells Products, Services and Solutions
Table 89. Revenue (US$ Million) in Competent Cells Business of Lucigen (2020-2025)
Table 90. Lucigen Recent Developments
Table 91. Zymo Research Basic Information List
Table 92. Zymo Research Description and Business Overview
Table 93. Zymo Research Competent Cells Products, Services and Solutions
Table 94. Revenue (US$ Million) in Competent Cells Business of Zymo Research (2020-2025)
Table 95. Zymo Research Recent Developments
Table 96. Bio-Rad Laboratories Basic Information List
Table 97. Bio-Rad Laboratories Description and Business Overview
Table 98. Bio-Rad Laboratories Competent Cells Products, Services and Solutions
Table 99. Revenue (US$ Million) in Competent Cells Business of Bio-Rad Laboratories (2020-2025)
Table 100. Bio-Rad Laboratories Recent Developments
Table 101. Bioline Basic Information List
Table 102. Bioline Description and Business Overview
Table 103. Bioline Competent Cells Products, Services and Solutions
Table 104. Revenue (US$ Million) in Competent Cells Business of Bioline (2020-2025)
Table 105. Bioline Recent Developments
Table 106. Delphi Genetics Basic Information List
Table 107. Delphi Genetics Description and Business Overview
Table 108. Delphi Genetics Competent Cells Products, Services and Solutions
Table 109. Revenue (US$ Million) in Competent Cells Business of Delphi Genetics (2020-2025)
Table 110. Delphi Genetics Recent Developments
Table 111. IBA GmBH Basic Information List
Table 112. IBA GmBH Description and Business Overview
Table 113. IBA GmBH Competent Cells Products, Services and Solutions
Table 114. Revenue (US$ Million) in Competent Cells Business of IBA GmBH (2020-2025)
Table 115. IBA GmBH Recent Developments
Table 116. Cell Applications Basic Information List
Table 117. Cell Applications Description and Business Overview
Table 118. Cell Applications Competent Cells Products, Services and Solutions
Table 119. Revenue (US$ Million) in Competent Cells Business of Cell Applications (2020-2025)
Table 120. Cell Applications Recent Developments
Table 121. BioDynamics Laboratory Basic Information List
Table 122. BioDynamics Laboratory Description and Business Overview
Table 123. BioDynamics Laboratory Competent Cells Products, Services and Solutions
Table 124. Revenue (US$ Million) in Competent Cells Business of BioDynamics Laboratory (2020-2025)
Table 125. BioDynamics Laboratory Recent Developments
Table 126. Scarab Genomics Basic Information List
Table 127. Scarab Genomics Description and Business Overview
Table 128. Scarab Genomics Competent Cells Products, Services and Solutions
Table 129. Revenue (US$ Million) in Competent Cells Business of Scarab Genomics (2020-2025)
Table 130. Scarab Genomics Recent Developments
Table 131. GCC Biotech Basic Information List
Table 132. GCC Biotech Description and Business Overview
Table 133. GCC Biotech Competent Cells Products, Services and Solutions
Table 134. Revenue (US$ Million) in Competent Cells Business of GCC Biotech (2020-2025)
Table 135. GCC Biotech Recent Developments
Table 136. SMOBIO Technology Basic Information List
Table 137. SMOBIO Technology Description and Business Overview
Table 138. SMOBIO Technology Competent Cells Products, Services and Solutions
Table 139. Revenue (US$ Million) in Competent Cells Business of SMOBIO Technology (2020-2025)
Table 140. SMOBIO Technology Recent Developments
Table 141. Edge BioSystems Basic Information List
Table 142. Edge BioSystems Description and Business Overview
Table 143. Edge BioSystems Competent Cells Products, Services and Solutions
Table 144. Revenue (US$ Million) in Competent Cells Business of Edge BioSystems (2020-2025)
Table 145. Edge BioSystems Recent Developments
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. Competent Cells Downstream Customers
Table 149. Competent Cells Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
Table 153. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Competent Cells Product Picture
Figure 2. Global Competent Cells Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Competent Cells Sales Value (2020-2031) & (US$ Million)
Figure 4. Competent Cells Report Years Considered
Figure 5. Global Competent Cells Players Revenue Ranking (2024) & (US$ Million)
Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Competent Cells Revenue in 2024
Figure 7. Competent Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 8. Chemically Competent Cells Picture
Figure 9. Electrocompetent Cells Picture
Figure 10. Global Competent Cells Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 11. Global Competent Cells Sales Value Market Share by Type, 2024 & 2031
Figure 12. Product Picture of Subcloning & Routine Cloning
Figure 13. Product Picture of Phage Display Library Construction
Figure 14. Product Picture of Toxic/Unstable DNA Cloning
Figure 15. Product Picture of High-Throughput Cloning
Figure 16. Product Picture of Protein Expression
Figure 17. Product Picture of Mutagenesis
Figure 18. Product Picture of Single-Stranded DNA Production
Figure 19. Product Picture of Bacmid Creation
Figure 20. Product Picture of Cre-Lox Recombination (PIR1/PIR2)
Figure 21. Global Competent Cells Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 22. Global Competent Cells Sales Value Market Share by Application, 2024 & 2031
Figure 23. North America Competent Cells Sales Value (2020-2031) & (US$ Million)
Figure 24. North America Competent Cells Sales Value by Country (%), 2024 VS 2031
Figure 25. Europe Competent Cells Sales Value, (2020-2031) & (US$ Million)
Figure 26. Europe Competent Cells Sales Value by Country (%), 2024 VS 2031
Figure 27. Asia Pacific Competent Cells Sales Value, (2020-2031) & (US$ Million)
Figure 28. Asia Pacific Competent Cells Sales Value by Region (%), 2024 VS 2031
Figure 29. South America Competent Cells Sales Value, (2020-2031) & (US$ Million)
Figure 30. South America Competent Cells Sales Value by Country (%), 2024 VS 2031
Figure 31. Middle East & Africa Competent Cells Sales Value, (2020-2031) & (US$ Million)
Figure 32. Middle East & Africa Competent Cells Sales Value by Country (%), 2024 VS 2031
Figure 33. Key Countries/Regions Competent Cells Sales Value (%), (2020-2031)
Figure 34. United States Competent Cells Sales Value, (2020-2031) & (US$ Million)
Figure 35. United States Competent Cells Sales Value by Type (%), 2024 VS 2031
Figure 36. United States Competent Cells Sales Value by Application (%), 2024 VS 2031
Figure 37. Europe Competent Cells Sales Value, (2020-2031) & (US$ Million)
Figure 38. Europe Competent Cells Sales Value by Type (%), 2024 VS 2031
Figure 39. Europe Competent Cells Sales Value by Application (%), 2024 VS 2031
Figure 40. China Competent Cells Sales Value, (2020-2031) & (US$ Million)
Figure 41. China Competent Cells Sales Value by Type (%), 2024 VS 2031
Figure 42. China Competent Cells Sales Value by Application (%), 2024 VS 2031
Figure 43. Japan Competent Cells Sales Value, (2020-2031) & (US$ Million)
Figure 44. Japan Competent Cells Sales Value by Type (%), 2024 VS 2031
Figure 45. Japan Competent Cells Sales Value by Application (%), 2024 VS 2031
Figure 46. South Korea Competent Cells Sales Value, (2020-2031) & (US$ Million)
Figure 47. South Korea Competent Cells Sales Value by Type (%), 2024 VS 2031
Figure 48. South Korea Competent Cells Sales Value by Application (%), 2024 VS 2031
Figure 49. Southeast Asia Competent Cells Sales Value, (2020-2031) & (US$ Million)
Figure 50. Southeast Asia Competent Cells Sales Value by Type (%), 2024 VS 2031
Figure 51. Southeast Asia Competent Cells Sales Value by Application (%), 2024 VS 2031
Figure 52. India Competent Cells Sales Value, (2020-2031) & (US$ Million)
Figure 53. India Competent Cells Sales Value by Type (%), 2024 VS 2031
Figure 54. India Competent Cells Sales Value by Application (%), 2024 VS 2031
Figure 55. Competent Cells Industrial Chain
Figure 56. Competent Cells Manufacturing Cost Structure
Figure 57. Channels of Distribution (Direct Sales, and Distribution)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 9.5% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What is the annual compound growth rate of the global Competent Cells market size from 2025 to 2031?
What was the global market size of Competent Cells in 2031?
What was the global market size of Competent Cells in 2025?
Which companies rank high in the global Competent Cells market?
Related Reports
Global Competent Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Competent Cells market size was US$ 2585 million in 2025 and is forecast to reach a readjusted size of US$ 4837 million by 2032 with a CAGR of 9.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 111
USD 4250.00
(Single User License)
Global Competent Cells Market Research Report 2026
The global Competent Cells market was valued at US$ 2585 million in 2025 and is anticipated to reach US$ 4837 million by 2032, at a CAGR of 9.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 149
USD 2900.00
(Single User License)
Competent Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Competent Cells was estimated to be worth US$ 2585 million in 2025 and is projected to reach US$ 4837 million, growing at a CAGR of 9.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 144
USD 3950.00
(Single User License)
Global Competent Cells Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Competent Cells market is projected to grow from US$ 2382 million in 2024 to US$ 4456 million by 2031, at a CAGR of 9.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 173
USD 4900.00
(Single User License)
Global Competent Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Competent Cells was estimated to be worth US$ 2382 million and is forecast to reach approximately US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 166
USD 5900.00
(Single User License)
Global Competent Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Competent Cells market size was US$ 2382 million in 2024 and is forecast to a readjusted size of US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 119
USD 4250.00
(Single User License)
Global Competent Cells Market Research Report 2025
The global market for Competent Cells was valued at US$ 2382 million in the year 2024 and is projected to reach a revised size of US$ 4456 million by 2031, growing at a CAGR of 9.5% during the forecast period.
Published Date: 2025-01-16
Pages: 110
USD 2900.00
(Single User License)
Global Competent Cells Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Published Date: 2024-04-17
Pages: 189
USD 5600.00
(Single User License)
Global Competent Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Published Date: 2024-04-16
Pages: 190
USD 5900.00
(Single User License)
Global Competent Cells Market Insights, Forecast to 2030
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Published Date: 2024-04-07
Pages: 127
USD 4900.00
(Single User License)
Global Competent Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Competent Cells market size was US$ 2585 million in 2025 and is forecast to reach a readjusted size of US$ 4837 million by 2032 with a CAGR of 9.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 111
USD 4250.00 (Single User License)Global Competent Cells Market Research Report 2026
The global Competent Cells market was valued at US$ 2585 million in 2025 and is anticipated to reach US$ 4837 million by 2032, at a CAGR of 9.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 149
USD 2900.00 (Single User License)Competent Cells - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Competent Cells was estimated to be worth US$ 2585 million in 2025 and is projected to reach US$ 4837 million, growing at a CAGR of 9.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 144
USD 3950.00 (Single User License)Global Competent Cells Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Competent Cells market is projected to grow from US$ 2382 million in 2024 to US$ 4456 million by 2031, at a CAGR of 9.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 173
USD 4900.00 (Single User License)Global Competent Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Competent Cells was estimated to be worth US$ 2382 million and is forecast to reach approximately US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 166
USD 5900.00 (Single User License)Global Competent Cells Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Competent Cells market size was US$ 2382 million in 2024 and is forecast to a readjusted size of US$ 4456 million by 2031 with a CAGR of 9.5% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 119
USD 4250.00 (Single User License)Global Competent Cells Market Research Report 2025
The global market for Competent Cells was valued at US$ 2382 million in the year 2024 and is projected to reach a revised size of US$ 4456 million by 2031, growing at a CAGR of 9.5% during the forecast period.
Published: 2025-01-16
Pages: 110
USD 2900.00 (Single User License)Global Competent Cells Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Published: 2024-04-17
Pages: 189
USD 5600.00 (Single User License)Global Competent Cells Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Published: 2024-04-16
Pages: 190
USD 5900.00 (Single User License)Global Competent Cells Market Insights, Forecast to 2030
Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.
Published: 2024-04-07
Pages: 127
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now